Nicardipine Hydrochloride (American Regent, Inc.)
Welcome to the PulseAid listing for the Nicardipine Hydrochloride drug offered from American Regent, Inc.. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | American Regent, Inc. |
| NON-PROPRIETARY NAME: | nicardipine hydrochloride |
| SUBSTANCE NAME: | NICARDIPINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2009-11-17 |
| END MARKETING DATE: | 0000-00-00 |
Nicardipine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nicardipine Hydrochloride from American Regent, Inc. |
| LABELER NAME: | American Regent, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/mL) |
| START MARKETING DATE: | 2009-11-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0517-0735_32b24699-3461-4e45-9567-7eb856aff5dc |
| PRODUCT NDC: | 0517-0735 |
| APPLICATION NUMBER: | ANDA090534 |
Other NICARDIPINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
